Following adults with inflammatory bowel disease through a research cohort and biobank
Collects samples from adults with active inflammatory bowel disease for a research biobank.
Plain-language title generated from the registry record
Registry title: Inflammatory Bowel Disease Cohort in Nantes
Key facts
- Where
- Nantes, FranceSee the 3 sites
Where in France
- CHU de NantesNantes, FranceTaking people
- Clinique Jules VerneNantes, FranceNot yet recruiting
- Hôpital Privé du ConfluentNantes, FranceNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nantes University Hospital
- Trial code
- NCT06256393
- Record updated
- 10 February 2025
- Original description
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active diseaseRead full original descriptionShow less
Cohorte Nantaise de Maladies Inflammatoires Chroniques Intestinales
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
Inclusion: Patients over 18 years of age; Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis; Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy; Patients who have given written consent to participate in the study and to keep biological samples for research purposes.
Exclusion: Patients with chronic inflammatory bowel disease quiescent at inclusion; Patients refusing to participate in the cohort; Patients with a contraindication to general anaesthesia; Vulnerable patients (under court protection, curators, guardians).